Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 4,028 | 3,637 | 4,140 | 5,483 | 6,028 |
| Operating Income | -4,028 | -3,637 | -4,140 | -5,483 | -6,028 |
| Other Income | 1,137 | 45 | -201 | -747 | -291 |
| Pre-tax Income | -2,891 | -3,592 | -4,341 | -6,230 | -6,319 |
| Net Income Continuous | -2,891 | -3,592 | -4,341 | -6,230 | -6,319 |
| Net Income | $-2,891 | $-3,592 | $-4,341 | $-6,230 | $-6,319 |
| EPS Basic Total Ops | -0.48 | -1.31 | -1.96 | -2.88 | -2.92 |
| EPS Basic Continuous Ops | -0.49 | -1.31 | -1.96 | -2.88 | -2.92 |
| EPS Diluted Total Ops | -0.48 | -1.31 | -1.96 | -2.88 | -2.92 |
| EPS Diluted Continuous Ops | -0.49 | -1.31 | -1.96 | -2.88 | -2.92 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.31 | -2.92 | -4.80 | -5.20 |
| EBITDA(a) | $-3,736 | $-3,399 | $-3,908 | $-5,177 | $-5,706 |